Detalhe da pesquisa
1.
[89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial.
Eur J Nucl Med Mol Imaging
; 50(7): 1929-1939, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36826476
2.
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT).
Eur J Nucl Med Mol Imaging
; 50(9): 2830-2845, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246997
3.
18F-FDG PET-CT in rheumatoid arthritis patients tapering TNFi: reliability, validity and predictive value.
Rheumatology (Oxford)
; 61(SI): SI6-SI13, 2022 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34791068
4.
FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial.
Eur J Nucl Med Mol Imaging
; 49(10): 3452-3469, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35435497
5.
[18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial.
Eur J Nucl Med Mol Imaging
; 49(6): 1970-1984, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34981165
6.
Quantitative classification and radiomics of [18F]FDG-PET/CT in indeterminate thyroid nodules.
Eur J Nucl Med Mol Imaging
; 49(7): 2174-2188, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35138444
7.
Medical imaging and nuclear medicine: a Lancet Oncology Commission.
Lancet Oncol
; 22(4): e136-e172, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33676609
8.
Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer.
Eur J Nucl Med Mol Imaging
; 48(2): 469-476, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32617640
9.
Optimal use of [18F]FDG-PET/CT in patients with fever or inflammation of unknown origin.
Q J Nucl Med Mol Imaging
; 65(1): 51-58, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31271266
10.
Follow-up imaging after cryoablation of clear cell renal cell carcinoma is feasible using single photon emission computed tomography with 111In-girentuximab.
Eur J Nucl Med Mol Imaging
; 47(8): 1864-1870, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31768601
11.
Imaging Diagnosis and Follow-up of Advanced Prostate Cancer: Clinical Perspectives and State of the Art.
Radiology
; 292(2): 273-286, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31237493
12.
Impact of Ga-68-PSMA PET/CT on management in prostate cancer patients with very early biochemical recurrence after radical prostatectomy.
Eur J Nucl Med Mol Imaging
; 46(4): 901-907, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30617554
13.
The EANM practical guidelines for sentinel lymph node localisation in oral cavity squamous cell carcinoma.
Eur J Nucl Med Mol Imaging
; 46(3): 623-637, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30564849
14.
EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT).
Eur J Nucl Med Mol Imaging
; 46(12): 2536-2544, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31440799
15.
Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma.
Eur J Nucl Med Mol Imaging
; 46(9): 1931-1939, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31172212
16.
Consensus on molecular imaging and theranostics in prostate cancer.
Lancet Oncol
; 19(12): e696-e708, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30507436
17.
Preoperative stratification of cytologically indeterminate thyroid nodules by [18F]FDG-PET: can Orpheus bring back Eurydice?
Eur J Nucl Med Mol Imaging
; 50(4): 975-979, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36658413
18.
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems.
Eur J Nucl Med Mol Imaging
; 45(3): 412-422, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29192365
19.
Correction to: Dosimetry in clinical radionuclide therapy: the devil is in the detail.
Eur J Nucl Med Mol Imaging
; 45(4): 676, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29322210
20.
The revision of the pharmaceutical legislation - it is time to act for nuclear medicine in Europe.
Eur J Nucl Med Mol Imaging
; 51(1): 20-24, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37867178